Patents expiring in 2030

US 7659283

Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659268

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659082

Methods for identifying analgesic agents

Xenon Pharmaceuticals Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659278

Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases

APREA AB · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659081

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7658364

Ocular therapeutic agent delivery devices and methods for making and using such devices

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659115

Nucleic acid encoding human transductin-1 polypeptide

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659280

2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659403

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659285

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

ACADIA Pharmaceuticals Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659306

Method of increasing gastric emptying

The Board of Regents of the University of Texas System · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659309

Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659252

Transdermal delivery peptides and method of use thereof

UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659371

Patched polypeptides and uses related thereto

The Regents of the University of California · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659269

Substituted indolealkanoic acids

The Institute for Pharmaceutical Discovery, LLC · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659361

Maleamic acid polymer derivatives and their bioconjugates

Nektar Therapeutics · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7658923

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

The Board of Regents of the University of Texas System · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7659267

1,3-Benzothiazinone derivatives, process for producing the same use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662820

Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon

SanRx Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662923

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662815

Diaryl ether β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662860

3D-structure model of SARS coronavirus 3CL protease and anti-SARS drugs

Shanghai Lead Discovery Pharmaceuticals Limited Company · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662910

Inhibitors for the soluble epoxide hydrolase

The Regents of the University of California · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662365

Polymer conjugates of opioid antagonists

Nektar Therapeutics · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662814

4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors

Laboratories Almirall, S.A. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662999

Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases

The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662397

Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662568

Immunoliposome-nucleic acid amplification (ILNAA) assay

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662800

Hyaluronic acid derivatives

Jasper Ltd. Liability Co. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662408

Sustained-release preparations

Takeda Pharmaceutical Company Limited · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662573

Methods for evaluating osteoarthritis risk

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662974

Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same

Takeda Pharmaceutical Company Limited · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662394

Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662592

Bacteriocin inducer peptides

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662395

Method of enhancing a targeted immune response against tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662380

ZAQ ligand-1 antibodies and uses thereof

Takeda Pharmaceutical Company Limited · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662779

Triazolyl macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662780

Administering hypocretin to obese individuals

The Regents of the University of California · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662619

Sol-fusin: use of GP64-6His to catalyze membrane fusion

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7662607

Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

New Century Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666989

Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof

Beijing Sunbio Biotech Co. Ltd. · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666448

Skin cleansing article

Sakura Properties, LLC · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7668662

Patient-specific dosimetry

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666867

Heteroindanes: a new class of potent cannabimimetic ligands

UNIVERSITY OF CONNECTICUT · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666404

Glanders/meliodosis vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666427

HIV vaccines based on Env of multiple clades of HIV

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666674

Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7666411

Methods of treating and preventing colitis involving IL-13 and NK-T cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)